Sharon Arrol

Sharon Arrol has a diverse work experience spanning over 20 years in the pharmaceutical industry. Sharon is currently employed at Rallybio as the Executive Director and Head of Bioanalytical Development since April 2023.

Before joining Rallybio, Sharon worked at Alexion Pharmaceuticals, Inc. for almost 8 years, starting in October 2015 as a Director and progressing to the role of Associate Director for a brief period in September 2015. Sharon remained with Alexion Pharmaceuticals, Inc. until April 2023.

Prior to their tenure at Alexion Pharmaceuticals, Inc., Sharon worked at Pfizer for almost 2 years as a Principal Scientist from September 2013 to September 2015. Sharon also worked at Pfizer Inc as a Scientific Leader from September 2007 to July 2012.

Sharon's early work experience includes a role as a Senior Scientist at CuraGen Corporation from 2002 to 2007.

Overall, Sharon Arrol has held various roles throughout their career, showcasing a strong background in scientific leadership and expertise in bioanalytical development.

Sharon Arrol holds a Doctor of Philosophy (Ph.D.) degree in Biochemistry from The University of Manchester. Unfortunately, no specific information regarding the start and end years of their education was provided.